Robert F. Kennedy Jr.’s revamped Advisory Committee on Immunization Practices has struck its first blow against established vaccine practice, recommending against the use of flu shots that contain a preservative that has been used in shots for decades. More: With
read moreA Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, with Pride Month nearing its end, the vast majority have acknowledged the celebration in some way. More: GSK, Gilead,
read moreThe CDC’s Advisory Committee on Immunization Practices has blessed Merck’s new respiratory syncytial virus shot Enflonsia, but the decision was hardly resounding from Robert F. Kennedy Jr.’s newly formed panel of advisors. More: CDC immunization advisory panel endorses Merck's new
read moreHervé Hoppenot is retiring after 11 years spent growing Incyte from a one-drug operation to a competitive commercial drugmaker. His successor, Bill Meury, comes with a track record of dealmaking. More: Incyte waves goodbye to longtime CEO Hervé Hoppenot as
read moreLess than two months after Vor Bio telegraphed a strategic review, the former cell therapy biotech has made a surprise comeback with a potential $4 billion deal licensing a China-made autoimmune asset. More: Vor Bio's surprise B revival deal for
read moreAnother of Publicis Groupe’s health-focused agencies is shaking up its executive team this week, as Saatchi & Saatchi Wellness announced Wednesday the appointments of three new leaders. More: Saatchi & Saatchi Wellness nets new president plus creative and client execs
read more© 1994 - 2026 B.M. Pharmaceuticals